TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biomedola AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,182
|
914
|
762 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
828
|
703
|
526 |
| EBITDA |
790
|
703
|
526 |
| Total assets |
5,111
|
4,272
|
3,977 |
| Current assets |
3,133
|
2,426
|
2,074 |
| Current liabilities |
212
|
140
|
129 |
| Equity capital |
4,580
|
3,848
|
3,574 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
89.6%
|
90.1%
|
89.9% |
| Turnover per employee |
1,182
|
914
|
762 |
| Profit as a percentage of turnover |
70.1%
|
76.9%
|
69.0% |
| Return on assets (ROA) |
16.2%
|
16.5%
|
13.3% |
| Current ratio |
1477.8%
|
1732.9%
|
1607.8% |
| Return on equity (ROE) |
18.1%
|
18.3%
|
14.7% |
| Change turnover |
204
|
175
|
-331 |
| Change turnover % |
21%
|
24%
|
-30% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.